FDA Weighs Risk Of Antipsychotic Drugs From FDA, AstraZeneca PLC, And Pfizer Inc. For Kids

WASHINGTON (Reuters) - Three antipsychotic drugs appear to work in children and teens but their risks must be weighed as the makers aim to promote the medicines for youth, U.S. drug reviewers said in documents released on Friday.

MORE ON THIS TOPIC